|
- Endo - Home | Introducing Keenova and Par Health
Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products Stay tuned for updates
- Mallinckrodt and Endo to Combine to Create a Global, Scaled . . .
Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the transaction and intend to separate that business from the combined company at a later date
- Investors | Endo - Overview
Mallinckrodt and Endo have merged to create a global, scaled, diversified therapeutics leader Visit our new Investor Relations website at ir mallinckrodt com for up-to-date investor relations information and subscribe to email alerts
- Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo is providing the following financial guidance for the full year ending December 31, 2025 based on Endo's current views, beliefs, estimates and assumptions
- Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only . . .
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies Our passionate team members collaborate to develop and deliver these essential medicines
- Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
As announced on March 13, 2025, the proposed Mallinckrodt and Endo transaction envisions the spin-off of the combined generic pharmaceuticals businesses and Endo's sterile injectables business into a new standalone entity separate from the remaining branded pharmaceuticals business
- Endo Launches New Peyronies Disease Campaign: I Got Somebody
Through this new campaign, Endo is encouraging men to overcome their fear and discuss PD and nonsurgical treatment options so they can be informed and help others by sharing their experiences This shared knowledge helps individuals make informed decisions by leveraging trusted recommendations
- Financial Information - Endo International plc
© 2024 Endo, Inc or one of its affiliates Privacy Legal Code of Conduct Corporate Compliance Site Map Company Purpose Leadership History Policies Statements Contact Locations Products Capabilities Focus Areas Products Manufacturing Suppliers Research Development R D Approach Pipeline Clinical Research Grants Contact Us 1-800-462-ENDO
|
|
|